Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Biote Affirms FY2025 Sales Guidance of $202.00M-$208.00M vs $205.31M Est

Author: Benzinga Newsdesk | May 07, 2025 03:25pm
Biote (NASDAQ:BTMD) affirms FY2025 sales outlook from $202.00 million-$208.00 million to $202.00 million-$208.00 million vs $205.31 million estimate.

Posted In: BTMD

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist